Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon Pharmaceuticals Inc. has announced equity inducement grants to eleven new non-officer employees, consisting of 32,758 share options and 19,013 restricted share units (RSUs). These grants were approved by the Compensation Committee and were material to the employees joining the company, in accordance with Nasdaq Listing Rule 5635(c)(4). The share options have an exercise price of $64.19 and vest over four years, while the RSUs vest over four anniversaries of the grant date.